Small Pharmaceuticals

FDC Ltd.

FDC

Market Cap
₹7,000 Cr.
P/E
24.87

FDC Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
7,000 Cr
PE
PE
24.87
Prom Holding
Prom Holding
69.66 %
ROE (%)
ROE (%)
11.70
ROCE (%)
ROCE (%)
11.70
Div Yield (%)
Div Yield (%)
-
Sales
Sales
2,170 Cr
OPM (%)
OPM (%)
15.33 %
Debt to Equity
Debt to Equity
-
Institutions
Institutions
8.69 %
Individual < 2 lac
Individual < 2 lac
12.58 %
No. of Shareholders
No. of Shareholders
52,730
View more
Edit Ratio's

About

Founded in 1936, FDC Limited is a leading pharmaceutical company in India, known for specializ… Read more
Low
313
52W Range
High
528
  • FDC
  • Sanofi India
  • Bliss GVS Pharma
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

0.15 %
(as of Jul 22)
Historic
Anti - Diabetes - Market Share
2.78 %
(as of Jul 22)
Historic
Anti-Infectives - Market Share
0.03 %
(as of Feb 21)
Historic
Anti-Malarial - Market Share
0.75 %
(as of Nov 21)
Historic
Blood Related - Market Share
0.29 %
(as of Jul 22)
Historic
Cardiovascular - Market Share
0.54 %
(as of Nov 21)
Historic
Dermatology - Market Share

Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up - Formulation

Location Wise Break-Up - Bulk Drugs

Location Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • Domestic Sales Growth - YoY (%)
      Source
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Brands

    Electral

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Suppliers

    • Sayaji Industries Ltd.

    FAQs on FDC Ltd. Business

    FDC Limited is a renowned pharmaceutical company in India, established in 1936. It focuses on producing top-notch products such as Oral Rehydration Salts (ORS) and prescription formulations with internationally accredited manufacturing units.

    FDC major competitors are Sanofi India, Bliss GVS Pharma, Zota Health Care, Orchid Pharma, Guj. Themis Biosyn, Gufic Biosciences, Strides Pharma Scien.
    Market Cap of FDC is ₹7,000 Crs.
    While the median market cap of its peers are ₹4,921 Crs.

    FDC seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice

    Company Filing

    Discussions & Analysis

    FDC Ltd.
    View the discussion on ValuePickr
    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material